The Annals Take our Readership Survey!
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     

The Annals of Pharmacotherapy: Vol. 30, No. 9, pp. 1024-1028.
© 1996 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dalla Costa, T
Right arrow Articles by Derendorf, H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dalla Costa, T
Right arrow Articles by Derendorf, H

Research Articles

AUIC--a general target for the optimization of dosing regimens of antibiotics?

T Dalla Costa and H Derendorf

OBJECTIVE: To present a systematic evaluation of the are under the inhibitory curve (AUIC) approach for the optimization of antibiotic dosing schedules for three major antibiotic classes (beta-lactams, quinolones, aminoglycosides). It has been proposed that an AUIC over 24 hours of at least 125 may be an applicable target parameter for the optimization of antibiotic dosing schedules across these antibiotic classes. Some limitations of this approach are presented and discussed. METHODS: A precise equation for the calculation of AUIC is derived. Moreover, a specific equation is derived for the situation that results in a trough concentration at the end of the dosing interval equal to the minimum inhibitory concentration (MIC). With the same three drugs used for deriving the target AUIC value (tobramycin, cefmenoxime, ciprofloxacin), different dosing regimens are simulated to obtain the target AUIC of 125. RESULTS: Very different serum concentration profiles can result in the same AUIC. In an example for cefmenoxime, dosing regimens of 1 g q6h and 4.2 g q24h resulted in equal AUIC values of 125, whereas the respective time above MIC differed dramatically (99% of the dosing interval for q6h vs. 36% for q24h). CONCLUSIONS: It does not seem valid to accept the proposed breakpoint AUIC target of at least 125 as an applicable value for determining the appropriate dosing schedule of these classes of antibiotics. Based on the limitations discussed about the AUIC approach, the same conclusion also holds for any other fixed AUIC breakpoint target value.


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
M. Mueller, A. de la Pena, and H. Derendorf
Issues in Pharmacokinetics and Pharmacodynamics of Anti-Infective Agents: Kill Curves versus MIC
Antimicrob. Agents Chemother., February 1, 2004; 48(2): 369 - 377.
[Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
J. J Schentag, A. K Meagher, and A. Forrest
Fluoroquinolone AUIC Break Points and the Link to Bacterial Killing Rates: Part 1: In Vitro and Animal Models
Ann. Pharmacother., September 1, 2003; 37(9): 1287 - 1298.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
M. M. Sanchez-Recio, C.-I. Colino, and A. Sanchez-Navarro
A retrospective analysis of pharmacokinetic/pharmacodynamic indices as indicators of the clinical efficacy of ciprofloxacin
J. Antimicrob. Chemother., March 1, 2000; 45(3): 321 - 328.
[Abstract] [Full Text] [PDF]


homecopy help contact us subscription past issues search current issue
Copyright © 1996 by Harvey Whitney Books Company.